Today (Saturday) at #ASH24 the MRFF DIAAMOND trial results will be presented:
- Oral 303: Efficacy & safety of avatrombopag combined with immunosuppression in treatment-naïve severe AA. Clinical results: 4.30pm, room 11 SDCC.
- Poster 1318: cellular & cell-free genomic results